Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DHA-PPQ vs AS-AQ for Malaria in Pregnancy
NCT01231113Phase 3Completed
- Sponsor
- Kwame Nkrumah University of Science and Technology
- Start
- Jul 2011
- Primary completion
- Dec 2012
- Modality
- Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of dihydroartemisinin + piperaquine in Malaria (2 arms), sponsored by Kwame Nkrumah University of Science and Technology. Primary endpoint: PCR-corrected parasitological cure rates at Day 42. Started Jul 2011; status: completed.
02
Drugs
dihydroartemisinin + piperaquine
03
Conditions
Malaria
Beyond the preview
Go deeper on NCT01231113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01231113.